Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models
1995 ◽
Vol 248
(3)
◽
pp. 513-524
◽
Keyword(s):
1982 ◽
Vol 42
(2)
◽
pp. 474-487
◽
Keyword(s):
Keyword(s):
1999 ◽
Vol 44
(3)
◽
pp. 201-208
◽
2016 ◽
Vol 9
(5)
◽
pp. 419-430
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):